Compare Intuitive Surgical, Inc. (ISRG) vs Jabil Inc (JBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Jabil Inc — how do they compare? Intuitive Surgical, Inc. trades at $400.88 (market cap $141.76B), while Jabil Inc trades at $369.19 (market cap $38.37B). The key difference: Intuitive Surgical, Inc. is far larger — about 3.7× Jabil Inc's market cap, and Jabil Inc pays a 0.09% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| ISRG | JBL | |
|---|---|---|
Market Cap | $141.76B | $38.37B |
Sector | Health | Technology |
52-Week High | $592.85 | $385.50 |
52-Week Low | $332.02 | $192.49 |
Enterprise Value | $136.54B | $40.90B |
Dividend Yield | — | 0.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $401.27, showing minimal daily movement with a slight 0.01% gain. The stock maintains a bullish technical trend, supported by strong fundamentals including consistent earnings beats and robust revenue growth, with 2025 revenue reaching $10.06 billion. Recent news highlights analyst upgrades and optimism around da Vinci 5 adoption, though U.S. procedure growth has slowed temporarily.
The outlook remains positive with a consensus price target of $518.10, implying significant upside. Key opportunities include expanding robotic surgery applications and high profitability margins. Risks involve competitive pressures from Medtronic and Johnson & Johnson, valuation concerns with a P/E of 46.02, and near-term procedure volatility. Institutional sentiment is strongly bullish, with 68% of analysts rating it a Buy.
JBL trades at $366.16, up 2.68% with strong technical momentum and bullish analyst sentiment. The stock shows solid fundamentals with consistent earnings beats, revenue growth to $33.6B projected for 2026, and expanding AI infrastructure opportunities. Recent UBS upgrade to Buy highlights AI revenue potential exceeding $20 billion by fiscal 2027.
Outlook remains positive with 50% analyst buy ratings and $448.29 consensus price target offering 22% upside. Key risks include execution challenges in scaling AI operations and competitive pressures in electronics manufacturing. The stock's elevated P/E of 45.83 requires continued strong earnings growth to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →
